Joseph Spaniol, MD
Surgery · Philadelphia, PANPI 1467794792
Payments from drug & device makers
Across 96 payments — averaging $38.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Apollo Endosurgery US Inc$848
- TELA Bio, Inc.$731
- AbbVie$630
- Johnson & Johnson$303
- Galderma Laboratories, L.p.$198
- Mesh Suture Inc$194
- plus $838 from 15 others
What the payments were for
- Travel & lodging$64217%
- Food & beverage$3,05982%
- Education$421%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Apollo Endosurgery US Inc | 10 | $848 |
| TELA Bio, Inc. | 10 | $731 |
| AbbVie(2 entities) | 27 | $630 |
| Johnson & Johnson | 11 | $303 |
| Galderma Laboratories, L.p. | 11 | $198 |
| Mesh Suture Inc | 1 | $194 |
| Motiva USA, LLC | 5 | $170 |
| Acumed LLC | 1 | $142 |
| Mentor Worldwide LLC | 5 | $102 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $85 |
| Avita Medical Americas, LLC | 1 | $68 |
| Convatec Inc. | 1 | $60 |
| Integra Lifesciences Corporation | 2 | $41 |
| Stryker | 1 | $39 |
| Smith+Nephew | 2 | $27 |
| RTI Surgical, Inc | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
| Polynovo North America LLC | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Novo Nordisk | 1 | $14 |
| Kls-martin L.p. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,743 in reported general payments places this provider in the 70th percentile of 1,424 surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 48 | $677 |
| Cephalexin | 23 | $211 |
| Gabapentin | 54 | $183 |
| ErythromycinErythromycin Base | 12 | $112 |
| Oxycodone Hcl | 12 | $79 |
Paid to pharmacies, not to this prescriber.
Other surgery in Philadelphia
- Giorgos KarakousisPhiladelphia$8.8M
- James MarkmannPhiladelphia$1.8M
- John MiuraPhiladelphia$1.3M
- Olwadamilola FayanjuPhiladelphia$668K
- Julia TchouPhiladelphia$555K
- Ali NajiPhiladelphia$539K
- Ashesh ShahPhiladelphia$328K
- Lisa RaePhiladelphia$318K
- Hooman YarmohammadiPhiladelphia$304K
- Arminder JassarPhiladelphia$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.